Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December ...

Published on October 20, 2022

This report describes three-dose monovalent COVID-19 vaccine effectiveness against COVID-19 hospitalization during Omicron predominance.

Continue reading on website
Other news

EARLY RELEASE: Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity-United States, 2009-10 Through 2021-22 Influenza Seasons

October 18, 2022
This report describes an analysis of influenza hospitalization risk and vaccination coverage in the United States by race and ethnicity during the 2009-10 flu season through the 2021-22 flu season.

EARLY RELEASE: Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival - Louisiana, August 9-September 5, 2022

October 21, 2022
This report describes a large monkeypox vaccination event at an LGBTQIA+ festival in Louisiana.